January 9 Health Systems HIV Experts release 6-month update for HIV opportunistic infection treatment PT January 2024 In the dynamic landscape of HIV prevention and treatment, the U.S. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV are at the forefront. Corey Diamond, PharmD
January 9 Health Systems COVID-19 Medications What pharmacists should know about DDIs for patients with COVID-19 PT January 2024 For clinicians who work in acute care settings, some practical guidance pertaining to drug–drug interactions (DDIs) for the treatment of patients with COVID-19 is finally available. Loren Bonner
February 7 Health Systems Kidney Disease Cystatin C eGFR studies uncover undetected kidney disease PT February 2024 The utility of cystatin C—a protein biomarker similar to creatinine—has often been overlooked in routine practice as an alternative measurement of estimated glomerular filtration rate (eGFR) in patients with kidney disease. Corey Diamond, PharmD
February 7 Health Systems Pulse Oximetry Attorneys General make urgent call to address racial bias in pulse oximetry PT February 2024 Pulse oximeters send beams of light through the skin to measure the amount of oxygen in the blood. Health care providers who rely on the technology have long known that the tool can yield inaccurate readings for people with darker skin. Sonya Collins
February 19 Health Systems OR Safety Ketamine case provides lessons on med safety in the OR PT May 2021 Medication errors in the operating room (OR) can easily occur, with anesthesiologists and nurse anesthetists administering medications much more frequently than other medical staff. Maria G. Tanzi, PharmD
February 19 Health Systems OR Safety Ketamine case provides lessons on med safety in the OR PT May 2021 Medication errors in the operating room (OR) can easily occur, with anesthesiologists and nurse anesthetists administering medications much more frequently than other medical staff. Maria G. Tanzi, PharmD
March 7 Health Systems Heart Failure How do SGLT-2 inhibitors compare for HFpEF treatment? PT March 2024 In the realm of CV conditions, treatment options that reduce hospitalizations are critical to providing care for patients with heart failure. CDC estimates that over 6 million Americans suffer from heart failure. Ariel L. Clark, PharmD
March 7 Health Systems Probiotic FDA warns hospitals not to give preterm infants probiotic products PT March 2024 For years, clinicians in hospital NICUs have been giving preterm infants probiotic products to prevent a life-threatening illness called necrotizing enterocolitis, which causes tissues in the lining of their bowels to become inflamed and die. Loren Bonner
March 7 Health Systems Epilepsy Study suggests undiluted levetiracetam is safe for pediatric patients PT March 2024 Levetiracetam has emerged as a favored choice for severe seizures due to its favorable profile, minimal adverse effects, few drug interactions, and lack of a necessity for therapeutic drug monitoring. Corey Diamond, PharmD